Oxidative modification of lipoprotein(a) and the effect of β-carotene

Metabolism

Volumn 41, Issue 11, 1992, Pages 1215-1224

  Naruszewicz, Marek ^a   Selinger, Elizabeth ^a   Davignon, Jean ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CHOLESTEROL; CHOLESTEROL ESTER; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; OXIDATION; PRIORITY JOURNAL;

ADULT; ANIMAL; BETA CAROTENE; CAROTENOIDS; CHOLESTEROL; COPPER; ELECTROPHORESIS, AGAR GEL; HUMAN; IODINE RADIOISOTOPES; LIPOPROTEIN(A); MACROPHAGES; MICE; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PERITONEAL CAVITY; SUPPORT, NON-U.S. GOV'T;

EID: 0026480941     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0026-0495(92)90012-Y     Document Type: Article

References (48)

1. Lipoprotein (a)—Heterogeneity and biological relevance
2. The mysteries of lipoprotein(a)
3. Protein composition of Lp(a) lipoprotein from human plasma
4. Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins
5. Lipoprotein Lp(a) is not a catabolic product of other apolipoprotein B containing lipoproteins
6. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages
7. Isolation, characterization and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a)
8. The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B
9. Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages
10. Enhanced macrophage degradation of biologically modified low density lipoprotein
11. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
12. Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
13. Probucol inhibits oxidative modification of low density lipoprotein
14. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
15. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits
16. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
17. Detection and quantitation of lipoprotein(a) in the arterial wall of 107 coronary bypass patients
18. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
19. Iodination of proteins, glycoproteins and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3-alpha, 6-alpha-diphenyl glycoluril (Iodogen)
20. Modification of the Recalde method for the isolation of human monocytes
21. Purification and cultivation of monocytes and macrophages
22. Superoxide initiates oxidation of low density lipoprotein by human monocytes
23. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein(a) and very-low density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein
24. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts
25. Modification of human low density lipoprotein by lipid peroxidation product 4-hydroxynonenal
26. Uptake and degradation of low density lipoprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesis
27. Cytochalasin B. Dissociation of pinocytosis and phagocytosis by peritoneal macrophages
28. Enhanced macrophage uptake of low density lipoprotein after self-aggregation
29. Procedure for determination of free and total cholesterol in micro or nanogram amounts suitable for studies with cultured cells
30. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method
31. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid
32. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism
33. A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB.
34. Protein measurement with the Folin phenol reagent
35. Simultaneous determination of plasma retinol, α-tocopherol, lycopene, α-carotene, and β-carotene by high-performance liquid chromatography
36. Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins
37. Lipid transfer protein-catalysed exchange of cholesteryl ester between high density lipoproteins and apo B-containing lipoproteins
38. In vitro studies on the aggregation of isolated lipoprotein(a) upon addition of lysolecithin
39. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein
40. Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages
41. Quantification of apo(a) and apoB in human atherosclerotic lesions
42. Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages
43. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta
44. Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at reoperation
45. Lipoprotein(a) is uniformly detectable in coronary atherectomy specimens obtained from primary and restenotic lesions after PTCA
46. Structural characteristics of Lp(a) extracted from human atherosclerotic plaques
47. β-carotene inhibits the oxidative modification of low-density lipoprotein
48. Beta carotene therapy for chronic stable angina